- Home
- CXAI vs LSTA Comparison
CXAI vs LSTA Comparison
Compare CXAI & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAI
- LSTA
- Stock Information
- Founded
- CXAI N/A
- LSTA 1980
- Country
- CXAI United States
- LSTA United States
- Employees
- CXAI N/A
- LSTA N/A
- Industry
- CXAI EDP Services
- LSTA Misc Health and Biotechnology Services
- Sector
- CXAI Technology
- LSTA Health Care
- Exchange
- CXAI Nasdaq
- LSTA Nasdaq
- Market Cap
- CXAI 22.4M
- LSTA 20.0M
- IPO Year
- CXAI N/A
- LSTA N/A
- Fundamental
- Price
- CXAI $1.01
- LSTA $2.65
- Analyst Decision
- CXAI
- LSTA Strong Buy
- Analyst Count
- CXAI 0
- LSTA 1
- Target Price
- CXAI N/A
- LSTA $15.00
- AVG Volume (30 Days)
- CXAI 713.7K
- LSTA 15.5K
- Earning Date
- CXAI 05-20-2025
- LSTA 05-08-2025
- Dividend Yield
- CXAI N/A
- LSTA N/A
- EPS Growth
- CXAI N/A
- LSTA N/A
- EPS
- CXAI N/A
- LSTA N/A
- Revenue
- CXAI $6,548,000.00
- LSTA $1,000,000.00
- Revenue This Year
- CXAI N/A
- LSTA N/A
- Revenue Next Year
- CXAI $60.00
- LSTA N/A
- P/E Ratio
- CXAI N/A
- LSTA N/A
- Revenue Growth
- CXAI N/A
- LSTA N/A
- 52 Week Low
- CXAI $0.76
- LSTA $1.87
- 52 Week High
- CXAI $3.76
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- CXAI 44.84
- LSTA 56.32
- Support Level
- CXAI $0.94
- LSTA $2.59
- Resistance Level
- CXAI $1.08
- LSTA $2.80
- Average True Range (ATR)
- CXAI 0.10
- LSTA 0.22
- MACD
- CXAI -0.01
- LSTA 0.00
- Stochastic Oscillator
- CXAI 14.23
- LSTA 62.07
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.